New Drugs Roundup: Dermatology

The July issue of Dermatology Times highlights some newly approved treatments in dermatology including:  Eskata for seborrheic keratosis; Actemra (tocilizumab, Genentech) for polyarticular juvenile idiopathic arthritis (PJIA); diacerein 1% ointment for epidemolysis bullosa (EB); Restylane Lift (hyaluronic acid, Galderma) for volumne loss in hands; Cimiza (certolizumab pegol) for moderate-to-severe psoriasis; and, an antimicrobial post-therapy gel (Sonoma) to be used after aesthetic procedures (such laser, microdermabrasion or chemical peels) to sooth itch and other treatment-associated irritations.